Freedom Peripheral Nerve Stimulator (PNS) System

FDA 510(k) K233162 · Curonix

Substantially Equivalent

510(k) numberK233162

Submission

Device name
Freedom Peripheral Nerve Stimulator (PNS) System
Applicant
Curonix
Pompano Beach, FL, US
Received
September 27, 2023
Decision date
June 20, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GZF – Stimulator, Peripheral Nerve, Implanted (Pain Relief)
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5870
Specialty
Neurology
Implant
Yes

Other 510(k)s with product code GZF

510(k)DeviceApplicantDecision
K253877StimTrial Neuromodulation SystemGZF · Special Bioventus, LLC08/26/2026SE
K243782StimTrial Neuromodulation SystemGZF · Traditional Bioventus, LLC07/16/2025SE
K243678TalisMann Neuromodulation SystemGZF · Traditional Bioventus, LLC07/03/2025SE
K232415Nalu Neurostimulation System for Peripheral Nerve StimulationGZF · Traditional Boston Scientific Neuromodulation08/21/2024SE
K221303Neuspera Nuity SystemGZF · Traditional Neuspera Medical, Inc.04/11/2023SE
K211965StimRouter Neuromodulation SystemGZF · Traditional Bioness, Inc.02/23/2022SE
K202781Neuspera Neurostimulation System (NNS)GZF · Traditional Neuspera Medical, Inc.08/27/2021SE
K200848Stimulator, Stimulator Kit, External Transmitter, External Transmitter KitGZF · Traditional Micron Medical Corporation08/14/2020SE
K200482StimRouter Neuromodulation SystemGZF · Special Bioness, Inc.03/27/2020SE
K190047StimRouter Neuromodulation SystemGZF · Traditional Bioness, Inc.10/31/2019SE

Questions and answers

When was Freedom Peripheral Nerve Stimulator (PNS) System cleared by the FDA?

Freedom Peripheral Nerve Stimulator (PNS) System (K233162) received a 510(k) decision of Substantially Equivalent on June 20, 2024, 267 days after the submission was received.

What is the product code of K233162?

The FDA product code is GZF – Stimulator, Peripheral Nerve, Implanted (Pain Relief), a Class II (moderate risk) device regulated under 21 CFR 882.5870.